Saeidifard Farzane, Medina-Inojosa Jose R, Supervia Marta, Olson Thomas P, Somers Virend K, Prokop Larry J, Stokin Gorazd B, Lopez-Jimenez Francisco
Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Department of Medicine, Northwell Health, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY.
Mayo Clin Proc Innov Qual Outcomes. 2020 Dec 1;4(6):611-626. doi: 10.1016/j.mayocpiqo.2020.07.017. eCollection 2020 Dec.
To investigate the effect of replacing sitting with standing on cardiovascular risk factors tested in clinical trials.
We searched databases from inception up to August 28, 2019, for studies examining the effect of replacing sitting with standing on fasting blood glucose, fasting insulin, and lipid levels; blood pressure; body fat mass; weight; and waist circumference in healthy adults. Differences in mean ± SD values were used for pooling the data and calculating the mean differences and CIs.
The search found 3507 abstracts. Nine clinical trials (8 randomized and 1 nonrandomized) with 877 (64.4% [n=565] women) participants met all inclusion criteria. The mean ± SD age was 45.34±5.41 years; mean follow-up was 3.81 months, and mean difference in standing time between the intervention and control groups was 1.33 hours per day. The follow-up fasting blood glucose and body fat mass values were slightly but significantly lower than baseline records in the intervention groups compared with control groups (-2.53; 95% CI, -4.27 to -0.79 mg/dL; and -0.75; 95% CI, -0.91 to -0.59 kg). The analysis for fasting insulin levels, lipid levels, blood pressure, weight, and waist circumference revealed no significant differences.
Replacing sitting with standing can result in very small but statistically significant decreases in fasting blood glucose levels and body fat mass with no significant effect on lipid levels, blood pressure, weight, and waist circumference. Replacing sitting with standing can be used as an adjunctive intervention to decrease the burden of cardiovascular risk factors but cannot be used as an alternative to physical activity to decrease sedentary time.
探讨在临床试验中用站立代替久坐对心血管危险因素的影响。
我们检索了从数据库创建至2019年8月28日的相关研究,以考察用站立代替久坐对健康成年人空腹血糖、空腹胰岛素、血脂水平、血压、体脂量、体重和腰围的影响。采用均值±标准差的差异来汇总数据并计算均值差异和置信区间。
检索到3507篇摘要。9项临床试验(8项随机试验和1项非随机试验)共877名参与者(64.4%[n = 565]为女性)符合所有纳入标准。平均±标准差年龄为45.34±5.41岁;平均随访时间为3.81个月,干预组和对照组之间站立时间的平均差异为每天1.33小时。与对照组相比,干预组随访时的空腹血糖和体脂量值略低于基线记录,但差异有统计学意义(-2.53;95%置信区间,-4.27至-0.79mg/dL;以及-0.75;95%置信区间,-0.91至-0.59kg)。对空腹胰岛素水平、血脂水平、血压、体重和腰围的分析显示无显著差异。
用站立代替久坐可使空腹血糖水平和体脂量出现非常小但具有统计学意义的下降,而对血脂水平、血压、体重和腰围无显著影响。用站立代替久坐可作为一种辅助干预措施来减轻心血管危险因素的负担,但不能替代体育活动来减少久坐时间。